Published in Ned Tijdschr Geneeskd on February 12, 2000
[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 1.10
[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 0.75
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med (1998) 3.97
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet (1994) 3.72
Cerebral function in diabetes mellitus. Diabetologia (1994) 2.82
Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet (2001) 2.45
Compatibility of insulin pens and cartridges. Lancet (1997) 2.13
[Atherosclerosis partly due to local vasculitis]. Ned Tijdschr Geneeskd (1994) 2.05
Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes (1976) 2.04
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
[Psychiatric drugs as risk factor in fatal heat stroke]. Ned Tijdschr Geneeskd (1995) 2.03
[Familial combined hyperlipidemia]. Ned Tijdschr Geneeskd (1996) 2.03
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest (2000) 1.98
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS (2001) 1.81
Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res (1998) 1.79
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71
Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet (1990) 1.71
First-trimester prenatal diagnosis for Huntington's disease with DNA probes. Lancet (1987) 1.70
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A (1991) 1.69
Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation (1999) 1.66
Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes (1996) 1.61
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J (2011) 1.60
Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. Eur J Clin Invest (2000) 1.56
[A Dutch family with familial Mediterranean fever]. Ned Tijdschr Geneeskd (1993) 1.49
Molecular genetics and gene expression in atherosclerosis. Int J Cardiol (2001) 1.46
The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med (2004) 1.46
Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) (2007) 1.43
Smoking and diabetes mellitus. Neth J Med (1996) 1.42
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci U S A (1989) 1.41
Islet-amyloid polypeptide in human plasma. Lancet (1990) 1.40
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia]. Ned Tijdschr Geneeskd (1994) 1.39
A polymorphic DNA marker that represents a conserved expressed sequence in the region of the Huntington disease gene. Am J Hum Genet (1988) 1.39
[Decrease in coronary heart disease mortality in 1974-1992 largely explainable by changes in cholesterol and smoking risk factors]. Ned Tijdschr Geneeskd (1995) 1.39
Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans. J Intern Med (1997) 1.38
[Postmenopausal estrogen substitution and the risk of atherosclerotic heart and vascular diseases]. Ned Tijdschr Geneeskd (1992) 1.37
[Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age]. Ned Tijdschr Geneeskd (2000) 1.36
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
[Tracing of patients with familial hypercholesterolemia in the Netherlands]. Ned Tijdschr Geneeskd (1999) 1.33
Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract (1991) 1.33
A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J Clin Invest (1990) 1.32
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation (1998) 1.27
Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. J Clin Endocrinol Metab (2000) 1.19
Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med (2004) 1.17
Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care (1996) 1.16
Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr Opin Lipidol (2000) 1.15
Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients. Clin Sci (Lond) (1997) 1.13
Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol (1997) 1.11
Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care (1998) 1.10
Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ (2001) 1.09
Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol (2000) 1.09
Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost (2000) 1.08
An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest (1996) 1.08
Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol (1997) 1.07
Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care (2000) 1.06
Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia. Lancet (1986) 1.06
Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes (1976) 1.06
The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet (1993) 1.03
Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med (1995) 1.03
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res (1999) 1.02
Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH). Am J Hum Genet (1988) 1.02
Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol (2001) 1.00
Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer (2000) 1.00
Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain (1999) 1.00
Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis (1999) 0.99
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest (1986) 0.99
Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties. J Biol Chem (1997) 0.98
[Sense and nonsense in the diagnosis of spontaneous hypoglycemia]. Ned Tijdschr Geneeskd (1989) 0.97
A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet (1999) 0.96
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res (2000) 0.96
Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism (2003) 0.96
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia. Arch Intern Med (1993) 0.96
Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol (1999) 0.95
C-peptide. Diabetes Care (1983) 0.95
Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Lancet (1988) 0.95
Apolipoprotein E genotyping on agarose gels. Clin Chem (1995) 0.94
The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev (1995) 0.94
Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus. J Lab Clin Med (1999) 0.94
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis (1995) 0.94
Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol (1997) 0.94
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. J Intern Med (2003) 0.93
A unique genetic and biochemical presentation of fish-eye disease. J Clin Invest (1995) 0.93
The 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol (1999) 0.92
Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol (1991) 0.92
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol (1999) 0.92
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis (1996) 0.91
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population. Hum Genet (1993) 0.91
Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res (1996) 0.91
Gender differences in diurnal triglyceridemia in lean and overweight subjects. Int J Obes Relat Metab Disord (2001) 0.91
Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia (1992) 0.91
The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis (2000) 0.90
Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles. Cardiovasc Res (2001) 0.90
[Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands]. Ned Tijdschr Geneeskd (2000) 0.90
Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb (1993) 0.90
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol (1995) 0.90